Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02922764
Title A Study of RGX-104 With or Without Nivolumab in Patients With Advanced Solid Malignancies and Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rgenix, Inc.
Indications

lymphoma

ovary epithelial cancer

fallopian tube carcinoma

Advanced Solid Tumor

lung small cell carcinoma

peritoneal carcinoma

lung non-small cell carcinoma

Therapies

RGX-104

Ipilimumab + RGX-104

Nivolumab + RGX-104

Carboplatin + Pembrolizumab + Pemetrexed Disodium + RGX-104

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center Recruiting Los Angeles California 90048 United States Details
University of Colorado Recruiting Aurora Colorado 80045 United States Details
Sarah Cannon Research Institute Recruiting Denver Colorado 80218 United States Details
Comprehensive Hematology Oncology Recruiting Saint Petersburg Florida United States Details
James Graham Brown Cancer Center Recruiting Louisville Kentucky 40202 United States Details
Ochsner Clinic Foundation Recruiting New Orleans Louisiana 70121 United States Details
Regions Hospital Recruiting Saint Paul Minnesota 55101 United States Details
CINJ Not yet recruiting New Brunswick New Jersey 08901 United States Details
Quantum Santa Fe Recruiting Santa Fe New Mexico 87505 United States Details
Columbia University Medical Center Recruiting New York New York 10032 United States Details
Oregon Health Sciences University Recruiting Portland Oregon 97239 United States Details
Thomas Jefferson University Hospital Recruiting Philadelphia Pennsylvania 19107 United States Details
Fox Chase Cancer Center Recruiting Philadelphia Pennsylvania 19111 United States Details
The Sarah Cannon Research Institute Recruiting Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field